Literature DB >> 10383835

Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor.

D L Sorrells1, C Meschonat, D Black, B D Li.   

Abstract

BACKGROUND: An abundance of eukaryotic initiation factor 4E (eIF4E), a rate-limiting initiation component in protein synthesis of mRNAs with long 5'-UTRs, has been shown to upregulate a number of oncogene products. Elevation of eIF4E protein has been detected both in infiltrating ductal carcinoma of the breast (IDCA) and in head and neck squamous cell carcinoma (HNSCC) specimens. We hypothesized that malignant progression in solid tumor is associated with progressive eIF4E gene amplification and protein overexpression in cells sampled from the tumor-free resection margin, transition zone (area adjacent to cancer), and tumor core (center of tumor).
MATERIALS AND METHODS: Thirty-eight resected specimens were evaluated: 10 IDCA, 13 HNSCC, and 15 benign specimens from similar sites of noncancer patients. IDCA and HNSCC specimens were divided into three different zones: (1) tumor core, (2) transition zone, and (3) tumor-free zone. Quantitative PCR for the eIF4E gene and Western blots for the eIF4E protein were performed on each of these zones and on the normal controls of benign tissue. Immunohistochemical staining was performed to localize the eIF4E protein overexpression in situ.
RESULTS: The eIF4E gene was amplified in the tumor core of both IDCA (3.8 +/- 1.4, P < 0.05, Student's t test) and HNSCC (4.3 +/- 1.4, P < 0.05) specimens. Similarly, the eIF4E protein was overexpressed in the cells from these same sites (17.4 +/- 7.3- and 14.0 +/- 9.7-fold elevation, respectively, P < 0.0001). In the transition zone of IDCA and HNSCC, the degrees of eIF4E gene amplification (4.2 +/- 1.0 and 3.7 +/- 1.2, respectively) and overexpression (4.0 +/- 1.0 and 4.4 +/- 4.6, respectively) were intermediate. In contrast, the eIF4E gene copy number and protein level were near baseline in the tumor-free zone.
CONCLUSIONS: Progressive eIF4E gene amplification and protein overexpression were present in cells sampled from the microscopically tumor-free margin to tumor core in surgical specimens of both HNSCC and IDCA. In this study, eIF4E gene amplification and protein overexpression appear to be associated with malignant progression in these two solid tumors. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383835     DOI: 10.1006/jsre.1999.5653

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  10 in total

Review 1.  Not just for housekeeping: protein initiation and elongation factors in cell growth and tumorigenesis.

Authors:  Sarah Thornton; Nisha Anand; Dan Purcell; Jonathan Lee
Journal:  J Mol Med (Berl)       Date:  2003-08-01       Impact factor: 4.599

2.  Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.

Authors:  Janet L Oblinger; Sarah S Burns; Jie Huang; Li Pan; Yulin Ren; Rulong Shen; A Douglas Kinghorn; D Bradley Welling; Long-Sheng Chang
Journal:  Exp Neurol       Date:  2017-06-10       Impact factor: 5.330

3.  Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis.

Authors:  Mona Diab-Assaf; Raefa Abou-Khouzam; Nina Saadallah-Zeidan; Khaled Habib; Nizar Bitar; Walid Karam; Bertrand Liagre; Steve Harakeh; Rania Azar
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

4.  Complementary cell-based high-throughput screens identify novel modulators of the unfolded protein response.

Authors:  Andrew M Fribley; Patricia G Cruz; Justin R Miller; Michael U Callaghan; Peter Cai; Neha Narula; Richard R Neubig; Hollis D Showalter; Scott D Larsen; Paul D Kirchhoff; Martha J Larsen; Douglas A Burr; Pamela J Schultz; Renju R Jacobs; Giselle Tamayo-Castillo; David Ron; David H Sherman; Randal J Kaufman
Journal:  J Biomol Screen       Date:  2011-08-15

5.  Decreased expression of ribosomal proteins in human age-related cataract.

Authors:  WeiYan Zhang; John Hawse; QingLing Huang; Nancy Sheets; Kevin M Miller; Joseph Horwitz; Marc Kantorow
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-01       Impact factor: 4.799

6.  Sirolimus as a potential radiosensitizer in squamous cell cancer of the head and neck.

Authors:  Eric T Shinohara; Amit Maity; Neha Jha; Robert A Lustig
Journal:  Head Neck       Date:  2009-03       Impact factor: 3.147

Review 7.  The molecular pathogenesis of head and neck cancer.

Authors:  Jonah D Klein; Jennifer R Grandis
Journal:  Cancer Biol Ther       Date:  2010-01-09       Impact factor: 4.742

8.  Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.

Authors:  Biljana Culjkovic; Katherine L Borden
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

9.  Expression of constitutively active 4EBP-1 enhances p27Kip1 expression and inhibits proliferation of MCF7 breast cancer cells.

Authors:  Hong Jiang; Jennifer Coleman; Robin Miskimins; W Keith Miskimins
Journal:  Cancer Cell Int       Date:  2003-02-18       Impact factor: 5.722

Review 10.  The role of protein elongation factor eEF1A2 in ovarian cancer.

Authors:  Jonathan M Lee
Journal:  Reprod Biol Endocrinol       Date:  2003-10-07       Impact factor: 5.211

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.